erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Konturek JW and Domschke W [Gastroparesis--physiopathology, diagnosis and the latest therapy]. 1998 Dtsch. Med. Wochenschr. pmid:9556697
Lilley LL and Guanci R Drug interaction triggers weakness. 1998 Am J Nurs pmid:9556673
Schwarz MI A man with dyspnea, productive cough, and chest radiograph showing hyperinflation and a diffuse nodular pattern. 1998 Chest pmid:9554657
Mortensen JE et al. In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida. 1998 Diagn. Microbiol. Infect. Dis. pmid:9554176
Mück W et al. Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. 1998 Eur. J. Clin. Pharmacol. pmid:9551706
Chakrabarti MK et al. Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine. 1998 Mar-Apr Chemotherapy pmid:9551241
Sachdeo RC et al. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy. 1998 J Clin Pharmacol pmid:9549651
Tanaka E and Breimer DD In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease. 1997 J Clin Pharm Ther pmid:9548204
Bertho G et al. Transferred nuclear Overhauser effect study of macrolide-ribosome interactions: correlation between antibiotic activities and bound conformations. 1998 Bioorg. Med. Chem. pmid:9547944
Li YX et al. Sensitive determination of erythromycin in human plasma by LC-MS/MS. 1998 J Pharm Biomed Anal pmid:9547699
Fitzgerald NB et al. Sonication-dependent electroporation of the erythromycin-producing bacterium Saccharopolyspora erythraea. 1998 Appl. Environ. Microbiol. pmid:9546194
Thomas AR et al. Prolongation of the QT interval related to cisapride-diltiazem interaction. 1998 Mar-Apr Pharmacotherapy pmid:9545159
Norcia LJ et al. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use. 1998 J. Antibiot. pmid:9544934
Williamson KM et al. Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers. 1998 Clin. Pharmacol. Ther. pmid:9542475
Jacobsen JR et al. Spontaneous priming of a downstream module in 6-deoxyerythronolide B synthase leads to polyketide biosynthesis. 1998 Biochemistry pmid:9538011
Lyon AJ et al. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. 1998 Arch. Dis. Child. Fetal Neonatal Ed. pmid:9536833
Choi MG et al. Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers. 1998 J. Pharmacol. Exp. Ther. pmid:9535992
Stout JE et al. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells. 1998 J. Antimicrob. Chemother. pmid:9533475
Nasher MA and Hay RJ Synergy of antibiotics against Streptomyces somaliensis isolates in vitro. 1998 J. Antimicrob. Chemother. pmid:9533473
Doucet-Populaire F et al. Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis. 1998 J. Antimicrob. Chemother. pmid:9533459
Molinari JA Multifactorial aspects of legionellosis. 1997 Compend Contin Educ Dent pmid:9533308
Salmon SA et al. Minimum inhibitory concentrations for selected antimicrobial agents against organisms isolated from the mammary glands of dairy heifers in New Zealand and Denmark. 1998 J. Dairy Sci. pmid:9532511
Constantine PA Antibiotic therapy and serum digoxin toxicity. 1998 Am Fam Physician pmid:9531908
den Hollander JG et al. Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. 1998 Antimicrob. Agents Chemother. pmid:9527789
Seppälä H et al. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. 1998 Antimicrob. Agents Chemother. pmid:9527769
Ponomareva TR and Smolianskaia AZ [Prevalence of markers characteristic for penicillinase plasmids in clinical strains of straphylococci]. 1976 Antibiotiki pmid:952503
Roberts GJ et al. Bacteremia of dental origin and antimicrobial sensitivity following oral surgical procedures in children. 1998 Jan-Feb Pediatr Dent pmid:9524970
Janicka G et al. [Resistance to antibiotics of Streptococcus pneumoniae strains]. 1997 Pol. Merkur. Lekarski pmid:9523479
Liu PC et al. Susceptibility of different isolates of Vibrio harveyi to antibiotics. 1997 Microbios pmid:9523424
Lester GD et al. Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radiolabeled markers in clinically normal ponies. 1998 Am. J. Vet. Res. pmid:9522953
Esposito S et al. Clinical comparison of cefaclor twice daily versus amoxicillin-clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis. 1998 Jan-Feb Clin Ther pmid:9522105
Service RF Hijacking a cell's chemical paths to make new antibiotics. 1997 Science pmid:9518361
Lalloo AK and Kanfer I Determination of erythromycin and related substances by capillary electrophoresis. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9518168
Lalloo AK et al. Development of a capillary electrophoretic method for the separation of the macrolide antibiotics, erythromycin, josamycin and oleandomycin. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9518167
Pankuch GA et al. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. 1998 Antimicrob. Agents Chemother. pmid:9517943
Sato K et al. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. 1998 Am. J. Respir. Crit. Care Med. pmid:9517602
Lu G et al. Effect of motilin and erythromycin on calcium-activated potassium channels in rabbit colonic myocytes. 1998 Gastroenterology pmid:9516395
Wynn RL Serious erythromycin interactions caused by inhibition of drug metabolism in the liver. 1996 Nov-Dec Gen Dent pmid:9515389
Noguchi N and Katayama J Expression in Pseudomonas aeruginosa of an erythromycin-resistance determinant that encodes the mphA gene for macrolide 2'-phosphotransferase I from Escherichia coli. 1998 Biol. Pharm. Bull. pmid:9514620
Perez-Trallero E et al. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. 1998 Eur. J. Clin. Microbiol. Infect. Dis. pmid:9512178
Jorgensen JH and McElmeel ML Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae. 1997 J. Antimicrob. Chemother. pmid:9511067
Williams JD et al. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. 1997 J. Antimicrob. Chemother. pmid:9511061
Manninen R et al. Reliability of disc diffusion susceptibility testing of Streptococcus pneumoniae and adjustment of laboratory-specific breakpoints. Finnish Study Group for Antimicrobial Resistance. 1998 J. Antimicrob. Chemother. pmid:9511033
Hay PE Therapy of bacterial vaginosis. 1998 J. Antimicrob. Chemother. pmid:9511031
Chen JD et al. Effects of octreotide and erythromycin on gastric myoelectrical and motor activities in patients with gastroparesis. 1998 Dig. Dis. Sci. pmid:9508540
Tsiaoussis I et al. Gallbladder fasting volume is reduced and gallbladder postprandial emptying is enhanced by intravenous erythromycin. 1998 Dig. Dis. Sci. pmid:9508522
Rivera P et al. [Collagenous colitis: presentation of 12 cases]. 1997 Gastroenterol Hepatol pmid:9508483
Kamoun A et al. [Pneumococcal infections: penicillin resistance and therapeutic implications]. 1995 Tunis Med pmid:9506153
Wong SL et al. The effect of erythromycin on the CYP3A component of sertindole clearance in healthy volunteers. 1997 J Clin Pharmacol pmid:9505999
Woodward A and Sillin LF Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer. 1998 Br J Surg pmid:9501836
Kataja J et al. Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. 1998 J. Infect. Dis. pmid:9498465
Wong PW et al. Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy. 1998 South. Med. J. pmid:9496876
Kondoh K and Hashiba M [Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa]. 1998 Nippon Jibiinkoka Gakkai Kaiho pmid:9493436
Pereda A et al. The loading domain of the erythromycin polyketide synthase is not essential for erythromycin biosynthesis in Saccharopolyspora erythraea. 1998 Microbiology (Reading, Engl.) pmid:9493390
Hoppe JE [Pertussis: current aspects of diagnosis, therapy and prevention]. 1998 Ther Umsch pmid:9492614
Anderson KL et al. Conjugal transfer of transposon Tn1545 into the cellulolytic bacterium Eubacterium cellulosolvens. 1998 Lett. Appl. Microbiol. pmid:9489031
Stout JE et al. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells. 1998 Diagn. Microbiol. Infect. Dis. pmid:9488830
Kurmanova KB et al. [Efficacy of pefloxacin in the treatment of complicated relapsing erysipelas]. 1997 Antibiot. Khimioter. pmid:9480650
Saito A [Emerging infectious diseases--Legionella pneumophila infections]. 1997 Nippon Naika Gakkai Zasshi pmid:9480307
Cheftel E et al. [Toxic food infection caused by Shigella flexneri in a military unit]. 1997 Sep-Oct Sante pmid:9480034
Gubina M et al. Septicaemia and meningitis with campylobacter fetus subspecies intestinalis. 1976 Infection pmid:947847
Vining LC Antibiotic tolerance in producer organisms. 1979 Adv. Appl. Microbiol. pmid:94753
Volmer DA and Hui JP Study of erythromycin A decomposition products in aqueous solution by solid-phase microextraction/liquid chromatography/tandem mass spectrometry. 1998 Rapid Commun. Mass Spectrom. pmid:9474800
Fazekas T et al. Suppression of erythromycin-induced early afterdepolarizations and torsade de pointes ventricular tachycardia by mexiletine. 1998 Pacing Clin Electrophysiol pmid:9474662
Schuetz EG et al. Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene. 1998 Arch. Biochem. Biophys. pmid:9473310
Mast WE and Burrows WM Erythema chronicum migrans in the United States. 1976 JAMA pmid:947268
Alegre M et al. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease]. 1997 Neurologia pmid:9471184
Gurevitz SL Erythromycin: drug interactions. 1997 J Dent Hyg pmid:9470569
Adair CD et al. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. 1998 Obstet Gynecol pmid:9469269
Dobson RL Diagnosis and treatment of eczema. 1976 JAMA pmid:946853
Tsuruta S et al. Inhibition of nifedipine metabolism in dogs by erythromycin: difference between the gut wall and the liver. 1997 J. Pharm. Pharmacol. pmid:9466344
Granovsky-Grisaru S et al. Effects of erythromycin on contractility of isolated myometrium from pregnant rats. 1998 Am. J. Obstet. Gynecol. pmid:9465824
Sadovnikova SF and Selina EV [Five years of sumamed on Russian market]. 1997 Antibiot. Khimioter. pmid:9463300
Zurabyan VA et al. [In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis]. 1997 Antibiot. Khimioter. pmid:9463297
Angeles BL et al. A bacterial sensitivity test to determine the effectiveness of minocycline HCI (Minocin), erythromycin (Erythrocin) and ampicillin (Ampicin) on the predominant microorganisms present in a diseased periodontium. 1994 Jun-Aug J Philipp Dent Assoc pmid:9462063
Nalepa P and Micherdzińska K [Severe pneumonia caused by Chlamydia pneumoniae in a patient treated with steroids for bronchial asthma]. 1997 Pol. Merkur. Lekarski pmid:9461730
Rampling A et al. Community-acquired Legionnaires' disease following minimal exposure to a contaminated source. 1997 J. Infect. pmid:9459407
Pfaller MA et al. In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample. 1997 Diagn. Microbiol. Infect. Dis. pmid:9458985
Pfaller MA et al. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group. 1997 Diagn. Microbiol. Infect. Dis. pmid:9458983
Borek AP et al. Evolving clinical problems with Streptococcus pneumoniae: increasing resistance to antimicrobial agents, and failure of traditional optochin identification in Chicago, Illinois, between 1993 and 1996. 1997 Diagn. Microbiol. Infect. Dis. pmid:9458976
Mathis C and Malbert CH Erythromycin gastrokinetic activity is partially vagally mediated. 1998 Am. J. Physiol. pmid:9458776
Yeates RA et al. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin. 1997 Int J Clin Pharmacol Ther pmid:9455717
Shirai R et al. [Analysis of cases allowed to cease erythromycin therapy for diffuse panbronchiolitis--comparative study between patients with cessation of the therapy and patients continuing the therapy]. 1997 Kansenshogaku Zasshi pmid:9455056
Granados MA and French L Antibiotic treatment in preterm PROM. 1998 J Fam Pract pmid:9451358
Cocuzza CE et al. High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study. 1997 Microb. Drug Resist. pmid:9442490
Chen B et al. Ameliorating effect of erythromycin on bleomycin-induced pulmonary fibrosis: role of alveolar macrophage activation and cytokine release. 1997 Respirology pmid:9441129
Fenton LJ and Light IJ Congenital syphilis after maternal treatment with erythromycin. 1976 Obstet Gynecol pmid:943741
Karbowski M et al. Induction of megamitochondria by some chemicals inducing oxidative stress in primary cultured rat hepatocytes. 1997 Biochim. Biophys. Acta pmid:9434138
Folwaczny C et al. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma]. 1997 Z Gastroenterol pmid:9432812
Freidank H [Diagnosis and therapy of Chlamydia pneumoniae and trachomatis]. 1997 Internist (Berl) pmid:9432510
Park HJ et al. Effect of erythromycin on gastric emptying in healthy individuals assessed by radio-opaque markers and plasma acetaminophen levels. 1997 J. Gastroenterol. pmid:9430010
Ross EA and Koo LC Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients. 1998 Am. J. Kidney Dis. pmid:9428453
Rooney G and Robinson A Look out for the hidden STD. 1997 Practitioner pmid:9425710
Passerini de Rossi BN et al. [Selection of Bvg- variants of Bordetella pertussis]. 1997 Apr-Jun Rev. Argent. Microbiol. pmid:9424628
Martins JC et al. Optimal detection of weak nJ(1H- 119Sn) couplings by gradient-enhanced 1D and 2D heteronuclear multiple-quantum correlation spectroscopy. Application to a novel tin derivative of erythromycin A. 1997 J. Magn. Reson. pmid:9424309
Midolo PD et al. Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. 1997 Pathology pmid:9423225
Marsden AF et al. Engineering broader specificity into an antibiotic-producing polyketide synthase. 1998 Science pmid:9422686
Ruzin A and Novick RP Glycerol monolaurate inhibits induction of vancomycin resistance in Enterococcus faecalis. 1998 J. Bacteriol. pmid:9422612
Guin JD et al. Antibiotic sensitivity of comedonal Propionibacterium acnes. 1979 Acta Derm. Venereol. pmid:94223
Fischman AJ et al. The role of positron emission tomography in pharmacokinetic analysis. 1997 Drug Metab. Rev. pmid:9421680